NewLink Genetics (NLNK) Announces Achievement of Two Ebola Zaire Vaccine Candidate Milestones by Merck (MRK)
Tweet Send to a Friend
NewLink Genetics Corporation (Nasdaq: NLNK), announced today that Merck (NYSE: MRK) has reached two key regulatory milestones for the Ebola ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
